NTRA EV/EBITDA Analysis
Updated 806h ago·SEC filings & market data
Key Takeaway
EV/EBITDA compares a company's total enterprise value to its operating earnings before interest, taxes, depreciation, and amortization; at -207.0x, NTRA has deeply negative EBITDA, so the ratio signals heavy operating losses rather than a normal valuation multiple.
Sector Performance
1th percentileNTRA
-207.0x
Sector Median
13.6x
Sector Avg
-29.8x
Prior Period
-209.5x(Aug 2026)
Deep Analysis
EV/EBITDA compares a company's total enterprise value to its operating earnings before interest, taxes, depreciation, and amortization; at -207.0x, NTRA has deeply negative EBITDA, so the ratio signals heavy operating losses rather than a normal valuation multiple.
This sits far below the sector median of 13.6x, placing the company in the 1th percentile among peers. The trailing eight quarters show a stable pattern, with the metric moving from -209.5x to -207.0x over recent periods, a quarter-over-quarter improvement of +1.2% but no usable year-over-year comparison. A highly negative and stable EV/EBITDA indicates the company's losses are persistent, and the slight QoQ narrowing does not change that the earnings base remains unprofitable.
Frequently Asked Questions
What does the EV/EBITDA tell investors about NTRA?
A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.
How is the EV/EBITDA calculated?
EV/EBITDA is calculated as: Enterprise Value / EBITDA.
Learn More About EV/EBITDA
The Formula
Enterprise Value / EBITDA
Why It Matters
A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.
Master NTRA's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full NTRA research report →NTRA
-207.0x
Sector Median
13.6x
Sector Avg
-29.8x
How NTRA's EV/EBITDA compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.